T A B L E O F C O N T E N T S
No studies evaluated oral care versus no oral care.
Authors' conclusions
Although low-quality evidence suggests that professional oral care could reduce mortality due to pneumonia in nursing home residents when compared to usual care, this finding must be considered with caution. Evidence for other outcomes is inconclusive. We found no high-quality evidence to determine which oral care measures are most effective for reducing nursing home-acquired pneumonia. Further trials are needed to draw reliable conclusions.
P L A I N L A N G U A G E S U M M A R Y

Mouth care for preventing pneumonia in nursing homes
Review question
Does oral (mouth) care cut down pneumonia (a lung infection) in nursing homes? We aimed to summarise the findings from studies known as 'randomised controlled trials' in order to identify whether mouth care helped prevent pneumonia in elderly people living in nursing homes or other care facilities, and which approach to mouth care was best.
Background
Pneumonia is common among elderly people living in nursing homes. Nursing home-acquired pneumonia (NHAP) is a bacterial infection of the lung that occurs in residents of long-term care facilities and nursing homes. Poor oral hygiene is considered to contribute to the likelihood of contracting an infection. Professional mouth care is a combination of brushing teeth and mucosa, cleaning dentures, using mouthrinse, and check-up visits to a dentist, while usual mouth care is generally less intensive, and is self-administered, or provided by nursing home staff without special training in oral hygiene. A second study (834 participants) that was stopped at interim analysis, with an average 1.13-year f ollow-up, reported that the HR of incidence rate of NHAP was 1.12 (0.84 to 1.50) A third study (2513 participants) reported that the RR of pneum onia-associated m ortality at 18-m onth f ollow-
Study characteristics
Incidence proportion (cumulative incidence) of NHAP
B A C K G R O U N D
Description of the condition
Residents of nursing homes and long-term care facilities are comprised predominantly of a geriatric population. Institutionalised older adults are prone to poor oral health because they have reduced access to professional dental care, and are unable to maintain the practice of good personal oral hygiene (Berg 2000; Gaszynska 2014) . Many studies have found that older adults require professional oral hygiene care as well as personal oral hygiene instruction (e.g. Frenkel 2000; Gaszynska 2014; Gluhak 2010; Petelin 2012) . The incidence of community-acquired pneumonia (CAP) requiring hospitalisation is 1.96 to 10 times higher amongst elderly nursing home residents than community-dwelling elderly people (Marrie 2002; Ronald 2008; Ticinesi 2016) , with a 2.29 times higher rate of 30-day mortality (Liapikou 2014) . This may be attributable to the particular characteristics of residents of nursing homes and long-term care facilities, as they tend to be older, have greater functional impairment, and to have increased comorbidities, polypharmacy, and dependence upon caregivers (Dudas 2000; Martínez-Moragón 2004) . Pneumonia occurring in residents of long-term care facilities and nursing homes can be termed nursing home-acquired pneumonia (NHAP); it closely resembles CAP, and may be caused by multidrug-resistant bacteria (Craven 2006; Mylotte 2002) . This is suggested by data from the United States and Asia (Micek 2007; Nakagawa 2014) , but is not confirmed by European data (Brito 2009; Ewig 2010) . Nursing home-acquired pneumonia is the leading cause of mortality among residents (Cho 2011; Nicolle 1996) . Its reported mean incidence ranges from 1 to 3.2 per 1000 patient days, with 600,000 emergency department admissions (El-Solh 2010; Medina-Walpole 1999; Muder 1998) . It has been suggested that NHAP may be caused by aspiration of oropharyngeal flora into the lung, and by failure of host defence mechanisms to eliminate aspirated bacteria (Scannapieco 2014; Verghese 1983) . Comorbidities considered to be risk factors for NHAP include the following (Klapdor 2012; Ticinesi 2016):
• physical impairment; • dementia;
• chronic obstructive pulmonary disease;
• mechanical ventilation;
• ageing.
A growing body of evidence shows that poor oral hygiene and oral hygiene-related factors (e.g. denture use (O'Donnell 2016), being edentulous (Abe 2008)) may be additional risk factors for aspiration pneumonia among the elderly, who have an increased rate of dental plaque colonisation as a possible reservoir for pathogenic organisms associated with CAP or NHAP (Bassim 2008; Janssens 2005; Scannapieco 2003) . A systematic review by Azarpazhooh 2006 concluded that there was fair evidence (II-2, grade B recommendation) of an association between pneumonia and oral health, and good evidence (I, grade A recommendation) that better oral health and frequent professional oral care reduced the occurrence or progression of respiratory disease among high-risk elderly living in nursing homes, and especially those in intensive care units. However, an RCT by Juthani-Mehta 2015 indicated that advanced oral care measures did not significantly reduce the incidence of radiographically-confirmed pneumonia or lower respiratory tract infection compared with usual care, in residents of nursing homes. Given that NHAP may be linked to oral hygiene, interventions for maintaining good oral hygiene might be of significant interest for this population.
Description of the intervention
It is widely believed that improved oral hygiene and frequent professional oral health care can be effective in reducing the incidence or progression of respiratory infection in residents of nursing homes and long-term care facilities (Azarpazhooh 2006; Scannapieco 2003; Sjögren 2008; Watando 2004) . Multiple oral care measures have been reinforced by the National Institute for Health and Care Excellence (NICE) guideline that introduced detailed oral care measures, and recommended that care home managers should ensure care home policies set out plans and actions to promote and protect residents' oral health (NICE guideline 2016). The nature of oral care measures that have been proposed is diverse, but they can be classified broadly as follows.
• Mechanical aids to remove plaque and debris from the oral cavity, for example:
• toothbrushing;
• swabbing with water.
• Topical (chemical) disinfection to reduce colonisation, for example:
• mouthrinse; • sprays; • liquids;
• gels.
Antiseptics are broadly defined to include saline, chlorhexidine, povidone-iodine, cetylpyridium, and others, but to exclude antibiotics (Shi 2013).
• Combination of mechanical plaque removal and topical disinfection, for example:
• swabbing with antiseptic;
• toothbrushing with antibacterial toothpaste;
• daily toothbrushing plus antiseptic rinse.
• Professional dental care, for example:
• aided toothbrushing;
• suction to remove excess fluid.
Oral care measures can be delivered at any frequency, by caregivers, nurses, dental care professionals, or dentists (Ekstrand 2013; Zuluaga 2012).
How the intervention might work
Increasing evidence suggests a link between colonisation of bacteria and respiratory infection and pneumonia. Gram-negative bacilli, such as Pseudomonas aeruginosa, Klebsiella pneumoniae, and Enterobacter species, have been suspected as causative pathogens of pneumonia (Craven 1992; Liapikou 2014). Dependent and frail elderly patients have a higher detection rate of gram-negative bacilli in their oropharyngeal cavities (Leibovitz 2003; Mylotte 1994; Palmer 2001) . Sumi 2007 showed that in a group of 138 dependent elderly, a potential respiratory pathogen colonised the dental plaques of 89 participants (64.5%). Aspiration of oropharyngeal fluid may cause translocation and colonisation of potential pulmonary pathogens in the lower respiratory tract and lungs (Gibbons 1989; Munro 2004; Whittaker 1996) ; the latter may cause aspiration pneumonia (Van der Maarel-Wierink 2013). Therefore, oral care measures that reduce the colonisation of bacteria could result in decreased risk of pneumonia. The risk of NHAP might be reduced by measures that mechanically disrupt the biofilm (such as manual or electric toothbrushing), by the use of oral antiseptics that may remain active on oral tissues for several hours after application, or both, thus reducing the build-up of plaque. For example, chlorhexidine (CHX) gluconate is a broad-spectrum antiseptic agent that reduces both gram-positive and gram-negative bacteria associated with respiratory tract infection; it can remain chemically active on tissue for up to six hours (Tantipong 2008) . Oral conditions of elderly people have been shown to be improved by rinsing with 0.12% CHX solution daily or weekly for six weeks (DeRiso 1996; Persseon 1991) . Similarly, manual oral brushing improves oral hygiene by reducing bacterial pathogen colonisation, and improves the swallowing reflex by stimulating gums (Yamaya 2001; Yoshino 2001) . With removal or disruption of the oral plaque, pneumonia could be significantly reduced (Shi 2013; Van der Maarel-Wierink 2013). Such oral care measures can be used alone, or in combination. For example, Yoshida 2001 found that brushing teeth after each meal and rinsing daily with 1% povidone-iodine, in conjunction with weekly professional dental care, significantly decreased the incidence of pneumonia in nursing homes.
Why it is important to do this review
Cochrane Oral Health undertook an extensive prioritisation exercise in 2014 to identify a core portfolio of clinically important review titles to be maintained in The Cochrane Library (Worthington 2015) . The dental public health expert panel identified this review as a priority title (ohg.cochrane.org/priority-reviews). Although good oral hygiene has been shown to play an important role in maintaining the oral health and well-being of institutionalised people, oral care measures have generally been afforded low priority in nursing homes. In some guidelines, such as British Thoracic Society guidance on the prevention of CAP, oral hy-giene is not mentioned (Lim 2009). Moreover, nurses have limited knowledge about providing mouth care in general (Frenkel 2000; Jablonski 2005; Pyle 2005) . Chiba 2009 reported that 32.4% of caregivers hesitated to provide oral care measures, which indicated their lack of knowledge about oral hygiene, but bespoke oral health education has been shown to have a positive effect on caregivers' knowledge and attitudes (Charteris 2001; Frenkel 2001; Frenkel 2002; Sjögren 2010) . A systematic review by Kaneoka 2015 found that mechanical oral cleaning significantly reduced the risk of fatal pneumonia in residents in nursing homes. However, no other kinds of oral care measures were evaluated, and no Cochrane systematic review has focused on this issue. We believe it is important to synthesise the evidence from randomised controlled trials of oral care interventions that have evaluated their effectiveness in reducing NHAP. Identifying effective oral care interventions is also an essential step towards improving oral health and quality of life for nursing home residents.
O B J E C T I V E S
To assess the effects of oral care measures for preventing nursing home-acquired pneumonia in residents of nursing homes and other long-term care facilities.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included parallel randomised controlled trials (RCTs) assessing the effects of oral care measures in residents of nursing homes and other long-term care facilities. We included cluster-RCTs, for which the unit of randomisation was the care facility. We excluded cross-over trials. Wu 2009 showed that trials carried out in China often used the terminology of randomisation in a broader way than was usual in other countries, such as the UK. Therefore, we contacted the authors of studies written in Chinese to request a description of the randomisation method used, and included only those trials where participants' allocation to treatment was random. We included all studies of oral care in which the purpose of the study was to reduce the incidence of pneumonia. We excluded studies that reported only intermediate outcomes, such as dental plaque and gingivitis, without providing data on pneumonia. We did not include studies for which the only available information was presented in an abstract, with no record of a full-text publication; since this would have provided insufficient information for a full assessment of risk of bias.
Types of participants
Residents of any age in nursing homes and other long-term care facilities (e.g. rehabilitation units, medical care facilities), regardless of oral health status (e.g. edentulous or dentate, using dentures, having physical or intellectual disabilities, being mechanically ventilated, using alternative feeding route). We excluded participants with pneumonia or respiratory infection at baseline.
Types of interventions
We included studies comparing oral care measure(s) for prevention of NHAP versus no treatment, placebo, usual care, or any other oral care measure(s) used to prevent NHAP (head-to-head trials).
• Intervention group: participants received clearly defined oral care measure(s), such as professional oral care (dentists, dental hygienists, nurse-assisted tooth brushing), oral rinse, or swab and topical decontamination with antiseptics, regardless of frequency, dosage, or formulation.
• Control group: participants received placebo or another specific oral care measure(s), no treatment, or usual care, including self-care.
We excluded studies in which topical antibiotics were used only in the intervention group.
Types of outcome measures
Primary outcomes
• Incidence, incidence proportion or prevalence of NHAP of any severity (diagnosis of NHAP should have been based on radiological results, clinical signs and symptoms, bacterial culture, or some synthetic criteria (American Thoracic Society 2005))
• Mortality (pneumonia-associated)
• Mortality (all-cause)
Secondary outcomes
• Change in systemic antibiotic use: this parameter included both the number of participants who had used systemic antibiotics, and the duration of antibiotic use
• Adverse reactions to the interventions (both local and systemic): this parameter referred to both the number of participants who had adverse reactions, and the number of adverse reactions
• Incidence or prevalence of fever: this included the proportion of participants with fever higher than 37.8°C, and prolonged number of febrile days
• Change in data on economics and quality of life • Oral health indices, such as gingival index, plaque index, bleeding index, periodontal index, etc.
Search methods for identification of studies
Electronic searches
Cochrane Oral Health's Information Specialist conducted systematic searches in the following databases for randomised controlled trials and controlled clinical trials. There were no language, publication year or publication status restrictions:
• Cochrane Oral Health's Trials Register (searched 15 November 2017; see Appendix 1);
• Cochrane Central Register of Controlled Trials (CENTRAL; in the Cochrane Register of Studies, searched 15 November 2017; see Appendix 2);
• MEDLINE Ovid (1946 to 15 November 2017; see Appendix 3);
• Embase Ovid (1980 to 15 November 2017; see Appendix 4);
• CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature; 1937 to 15 November 2017; see Appendix 5) .
Subject strategies were modelled on the search strategy designed for MEDLINE Ovid. Where appropriate, they were combined with subject strategy adaptations of the highly sensitive search strategy, designed by Cochrane for identifying randomised controlled trials and controlled clinical trials, as described in the Cochrane Handbook for Systematic Reviews of Interventions Chapter 6 (Lefebvre 2011). We also searched:
• Chinese Biomedical Literature Database (1978 to 20 November 2017; see Appendix 6);
• China National Infrastructure (1994 to 20 November 2017; see Appendix 7).
Searching other resources
Cochrane Oral Health's Information Specialist searched the following databases for ongoing trials:
• 
Data collection and analysis
Selection of studies
Two review authors independently screened the titles and abstracts of the reports retrieved by the searches. The search was designed to be sensitive, and include controlled clinical trials. These were filtered out early in the selection process if they were not randomised. We independently assessed eligibility according to the inclusion criteria, and obtained full-text copies of studies that appeared to meet the inclusion criteria, or when information in the title or the abstract was insufficient to allow us to make a clear judgement of eligibility. We resolved disagreements by discussion within the review author team. From the retrieved full-text articles, we discarded studies that clearly did not meet the inclusion criteria, and recorded the reasons for exclusion in the 'Characteristics of excluded studies' table.
Data extraction and management
Two review authors independently extracted data, and resolved disagreements by discussion. We created a data extraction form and piloted it on three of the included studies. Two review authors independently extracted the following data, and recorded them in the 'Characteristics of included studies' tables.
• Trial design, with inclusion and exclusion criteria, duration, setting, and location of the study.
• Demographic data of participants and risk factors for NHAP, including proportions of non-oral feeding, dysphagia, xerostomia, tongue coating, mechanical ventilation, and methicillin-resistant Staphylococcus aureus (MRSA).
• Diagnostic criteria of CAP or NHAP: outcomes, such as incidence of NHAP and mortality; oral, dental, and respiratory health status before and after treatment; any adverse reactions potentially relevant to the interventions; and timing of measurement.
• Management and intensity of specific interventions.
If any important data were missing, we contacted the authors of the study to request them. We collected data from multiple reports of single trials, and analysed them as from a single trial.
Assessment of risk of bias in included studies
Two review authors independently assessed risk of bias, and resolved disagreements by discussion. We used the Cochrane tool for assessing risk of bias (Higgins 2011a). We used seven items to assess the risk of bias in included studies.
For each item, we provided information from the trial report on measures taken to address possible bias, and arrived at a judgement of 'low risk', 'unclear risk' and 'high risk' of bias. We presented the seven domains and their descriptions below.
• Random sequence generation: selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence. We considered low risk of bias only if the generation of random numbers was clearly described. We considered an unclear description of random sequence generation with the phase 'stratified randomisation', 'block randomisation scheme', or 'randomisation completed by statistician or nurse' as having unclear risk of bias.
• Allocation concealment: selection bias (biased allocation to interventions) due to inadequate concealment of the allocation.
• Blinding of participants and personnel: performance bias due to knowledge of the allocated interventions by participants and personnel during the trial. We judged trials with completely different treatment arms that would be impossible to blind as having high risk of performance bias, even if details of blinding were not reported.
• Blinding of outcome assessment: detection bias due to knowledge of allocated interventions by outcome assessors.
• Incomplete outcome data: attrition bias due to quantity, nature, or handling of incomplete outcome data.
• Selective reporting: reporting bias due to selective outcome reporting.
• Other bias: bias due to problems not covered elsewhere in the table, such as baseline imbalance, contamination, or cointervention.
We classified the overall risk of bias in included studies as below. We summarised the risk of bias information graphically.
Risk of bias
Interpretation
In outcome In included studies
Low risk of bias
Plausible bias unlikely to seriously alter the results Low risk of bias for all key domains Most information was from studies at low risk of bias.
Unclear risk of bias Plausible bias that raised some doubt about the results
Unclear risk of bias for one or more key domains
Most information was from studies at low or unclear risk of bias
High risk of bias
Plausible bias that seriously weakened confidence in the results
High risk of bias for one or more key domains
The proportion of information from studies at high risk of bias was sufficient to affect interpretation of results
Measures of treatment effect
We treated the incidence proportion and prevalence of NHAP as dichotomous data (presence or absence) and the incidence of NHAP and mortality as time-to-event data when these were reported.
For dichotomous outcomes, we calculated the effect estimate as a risk ratio (RR) with 95% confidence interval (CI).
For time-to-event data, we expressed the treatment effect as a hazard ratio (HR) or a rate ratio. If the HR was not reported, we calculated the log HR and the standard error from available summary statistics or Kaplan-Meier curves, according to the methods proposed by Parmar 1998, or we requested the data from study authors. For continuous outcomes, when studies used the same scale, we used mean values and standard deviations (SDs) to express the estimate of effect as a mean difference (MD), with 95% confidence interval (CI). When different scales were used to measure the same outcome, we used the standardised mean difference (SMD), with 95% CI, as the effect measure. We anticipated that the number of participants reporting adverse reactions would be low, so we calculated a Peto odds ratio as the effect estimate.
Unit of analysis issues
We used the individual as the unit of analysis in this review, and we analysed only participant-level data. For cluster-RCTs analysed and reported by statistical measures that took clustering into account, we used the reported effect estimate and the standard error. When the investigators did not take clustering into consideration in their analyses, we attempted to re-analyse trial data using approximate analyses with an 'effective sample size'. We calculated and used external estimates of the intracluster correlation coeffi-cient (ICC) from similar trials (when available) to calculate the design effect (Deeks 2011).
Dealing with missing data
We contacted the first and corresponding authors of the trial to request missing details and summary statistics. Where no response was received, we used standard methods provided in the Cochrane Handbook for Systematic Reviews of Interventions to extract approximate summary statistics (Higgins 2011b).
Assessment of heterogeneity
For each meta-analysis, we assessed clinical heterogeneity by examining characteristics of studies and similarities between types of participants, interventions, and outcomes. We used Cochran's Q test to determine the presence of statistical heterogeneity at a significance level of 0.1. We used the I² statistic (plus 95% confidence interval) to quantify the degree of statistical heterogeneity as follow (Deeks 2011).
• 0% to 40% may indicate slight heterogeneity.
• 30% to 60% may indicate moderate heterogeneity.
• 50% to 90% may indicate substantial heterogeneity.
• 75% to 100% may indicate very substantial heterogeneity.
If substantial or very substantial heterogeneity existed, we provided a narrative description of the results instead of pooling data.
Assessment of reporting biases
To assess whether results were influenced by publication bias, we had planned to construct a funnel plot to assess asymmetry (assuming we had at least 10 trials). We had planned to use tests for funnel plot asymmetry, such as Egger's methods for continuous data (Egger 1997), and Begg's methods for dichotomous and timeto-event data (Begg 1994) .
Data synthesis
We undertook meta-analysis only when studies of similar comparisons reported the same outcomes. Our general approach to data synthesis was to use a random-effects model. With this approach, the CI for the pooled average intervention effect was wider than the value that would be obtained if a fixed effect approach was used, leading to a more conservative interpretation.
Subgroup analysis and investigation of heterogeneity
Had there been sufficient studies and heterogeneity, we would have considered subgroup analyses: types of oral care measures, trial design (cluster or parallel), length of follow-up, characteristics of participants (dentate or edentulous, with or without physical or intellectual disabilities), characteristics of oral care measures (e.g. concentrations of the solutions used, mechanical or topical intervention), and diagnostic criteria of the outcome (clinical or radiological).
Sensitivity analysis
To test the stability of the judgements we made during the review process, if necessary, we would have undertaken sensitivity analyses that included only trials at low risk of bias or only trials using intention-to-treat (ITT) analysis. If any meta-analyses had included several small trials and a single very large trial, we would have undertaken a sensitivity analysis comparing the effect estimates from both random-effects and fixed-effect models. If these were different, we would have reported on both analyses as part of the results section, and we would have considered possible interpretation.
Assessing the quality of the evidence
We had planned to assess the quality of the body of evidence for comparisons of clinical importance. At least two of the review authors, with no conflicts of interest, used GRADE criteria and GRADE profiler software to independently judge the quality of the evidence for our only comparison (Atkins 2004; Guyatt 2008; Schünemann 2011) . Evidence from RCTs is regarded as high quality, and our confidence in the body of evidence might be decreased due to study limitations (risk of bias), indirectness of the evidence, heterogeneity, imprecision of effect estimates, and risk of publication bias (see above Assessment of reporting biases). We classified the quality of a body of evidence into one of four categories: high, moderate, low, or very low (Guyatt 2008).
Summarising findings
We presented all important comparisons and key outcomes (pneumonia, death, and adverse effects) in the 'Summary of findings' tables, together with illustrative comparative risks, relative effect, numbers of participants and studies involved, quality of the evidence, and related comments. We used GRADEpro GDT to develop the 'Summary of findings' tables (GRADEpro GDT).
R E S U L T S Description of studies
Results of the search
Through our electronic searches and handsearches, we identified 1849 references. There were 1173 records after we removed duplicates. After scanning the titles and abstracts, we considered 18 reports to be potentially eligible, and obtained the full texts for further review. We included four studies (reported in eight articles) in this systematic review, and two studies await classification. We excluded the remaining eight records. The flow diagram is shown in Figure 1 . All four studies reported that they received non-industrial funding.
Participants
This review involved 3905 randomised participants. A total of 259 participants were lost during follow-up, leaving data from 3646 participants for analysis. Age and sex distribution of randomised participants was not described in Bourigault 2011 or Yoneyama 2002. In the remaining two studies, the mean age was 86.0, and the proportion of males was 24.1%. The inclusion criteria for participants in the included studies generally specified long-term care elderly residents of nursing homes, with no clinical pneumonia at baseline. In Adachi 2002, several patients had febrile days at the beginning of the trial, which did not exclude pneumonia, but suggested susceptibility to pneumonia.
Interventions
We classified the identified interventions into two broad groups.
• Professional oral care: oral health care with instruction or assistance of dental practitioners (dentists, dental hygienists, dental nurses), or caregivers with professional oral health-related knowledge, with interventions that consisted of more than basic oral care (brushing teeth and denture everyday), with or without oral disinfectants or mouth rinses
• Brushing teeth • Brushing or swabbing buccal mucosa and tongue • Cleaning denture(s) • Mouthrinse • Dental visit • Usual oral care: basic oral health care (brushing teeth and denture) without instruction or assistance of dental practitioners (dentists, dental hygienists, dental nurses), or caregivers with professional oral health-related knowledge, with or without the use of oral disinfectants or mouthrinse
• Brushing teeth (varying frequency)
• May also include swabbing buccal mucosa and tongue • May also include cleaning denture(s)
We evaluated the comparison between professional oral care and usual oral care, which was further divided into two subgroups according to the duration of follow-up:
• 18-month follow-up (Bourigault 2011);
• 24-month follow-up (Adachi 2002; Yoneyama 2002) .
In Juthani-Mehta 2015, the participants were followed up for a maximum of 2.5 years, but the follow-up duration was variable, with a mean follow-up of 1.13 years at termination of the trial. As such, we avoided including the number of events in any pooled calculation.
No studies were identified comparing oral care versus no oral care.
Measures of primary outcomes
Incidence rate of nursing home-acquired pneumonia (NHAP)
Incidence rate was defined as the number of new cases of pneumonia over the summed person-years/days of observation during the trial follow-up. The incidence rate of NHAP was reported in two studies (Bourigault 2011; Juthani-Mehta 2015).
Incidence proportion (cumulative incidence) of NHAP
We defined the incidence proportion as the proportion of the initially disease-free population that developed pneumonia during the trial follow-up. Incidence of NHAP was reported in three studies (Bourigault 2011; Juthani-Mehta 2015; Yoneyama 2002) .
Mortality (pneumonia-associated)
Three studies reported pneumonia-associated mortality during follow-up (Adachi 2002; Bourigault 2011; Yoneyama 2002) . This outcome was reported as death due to aspiration pneumonia in Adachi 2002, pneumopathy in Bourigault 2011, and pneumonia in Yoneyama 2002.
Mortality (all-cause)
Two studies reported the outcomes of all-cause death during follow-up (Adachi 2002; Juthani-Mehta 2015) . Adachi 2002 reported both the number and the reasons of death; the reasons of death were not reported in Juthani-Mehta 2015. Yoneyama 2002 stated that 51 participants died from causes other than pneumonia, but did not present these data by group.
Measures of secondary outcomes
Change in systemic antibiotic use
No study reported this outcome.
Adverse reactions to the interventions
Adverse events were reported in only one study (Juthani-Mehta 2015) . The adverse events reported in Juthani-Mehta 2015 were mostly oral cavity disturbances and dental staining, but the authors did not define oral cavity disturbances.
Incidence proportion or prevalence of fever
No study reported time-to-event data for incidence of fever. Two studies reported fever as an outcome (Adachi 2002; Yoneyama 2002) . In Adachi 2002, monthly proportions of participants with fever, and the average prevalence of participants with fever were described, but we could not extract the data for how many participants had suffered from febrile days during 24-month follow-up. In Yoneyama 2002, participants who had febrile days for more than seven cumulative days during two years were assumed to be participants with fever. Both studies considered a temperature 37.8°C or more as a feverish condition.
Change in data on economics and quality of life
No study reported change in economics as an outcome. Only one study reported quality of life at several time points (Yoneyama 2002) . They also assessed cognitive impairment and activities of daily living (ADLs).
Oral health indices
Yoneyama 2002 reported the change of debris index (DI). No other oral health indices were mentioned.
Studies awaiting classification
Two studies await classification (NCT00841074; Ohsawa 2003). See Characteristics of studies awaiting classification.
Excluded studies
We excluded six studies, reported in eight publications, for the reasons summarised below. See the 'Characteristics of excluded studies' table for details.
• Not an RCT: Bassim 2008 was a retrospective cohort study, Hollaar 2017 used a non-randomised controlled design, and Morino 2010 was a quasi-RCT.
• Did not assess pneumonia incidence or mortality: Izumi 2016; Quagliarello 2009; Watando 2004. Juthani-Mehta 2015 adopted a permuted block randomisation and Yoneyama 2002 used a random number table to achieve random sequence generation, which we considered as low risk of bias. The remaining two studies stated that allocation was random but provided no further details, and were therefore assessed at unclear risk of bias for this domain.
Risk of bias in included studies
Allocation concealment
In three studies, allocation concealment was not described in sufficient detail to determine risk of bias, and we rated these studies at unclear risk of bias. We assessed Juthani-Mehta 2015 at low risk of bias, because randomisation status of the home was revealed after enrolment in the trial.
Blinding
In all four studies, blinding of the participants and their caregivers to the allocated treatment was not possible because the active and control treatments differed significantly. We assessed them at high risk of performance bias. Blinding of outcome assessment was possible in all of the included studies, and was described in two studies, which we assessed as being at low risk of detection bias (Juthani-Mehta 2015; Yoneyama 2002). In the other two studies, there was insufficient information provided, and we judged the risk of detection bias to be unclear.
Incomplete outcome data
Juthani-Mehta 2015 applied intention-to-treat analysis, so we judged it to be at low risk of attrition bias. We judged two other studies as unclear risk of bias: Yoneyama 2002 excluded 12.2% of participants due to fatal causes other than pneumonia from the analysis; in Bourigault 2011, there was insufficient information available to determine the risk of attrition bias. Adachi 2002 included only some of the participants who had pneumonia-related outcomes, and we judged it at high risk of attrition bias.
Selective reporting
All four included studies reported the outcomes specified in their methods section in full, and we assessed them at low risk of reporting bias.
Other potential sources of bias
We assessed all four included studies at low risk of other bias.
Overall risk of bias
All four included studies were at high risk of bias overall. Two studies reported the incidence of NHAP (Bourigault 2011; Juthani-Mehta 2015). As Juthani-Mehta 2015 was stopped early, we considered it inappropriate to pool the data from this trial.
Effects of interventions
In the Bourigault 2011 trial, they presented a crude incidence rate of the first pneumonia episode of 3.3 (95% confidence interval (CI) 2.7 to 4.1) per 10,000 days in the experimental group and 5.1 (95% CI 4.5 to 5.9) in the control group. There was no evidence of a clear difference between professional oral care and usual oral care on the incidence of NHAP at 18 months (hazard ratio (HR) 0.65, 95% CI 0.29 to 1.46; one study, 2513 participants analysed; low-quality evidence; Analysis 1.1). In Juthani-Mehta 2015, the authors reported a HR of 1.12 (95% CI 0.84 to 1.50; 834 participants analysed) at the time that the study was stopped. Results in both studies were compatible with an increase or a decrease or no difference in the outcome as a result of professional oral care. Results were reported as percentages only, the number of events and numbers of participants on which this analysis was based were not reported. The authors reported the number of participants experiencing at least one episode of pneumonia (93 people in the experimental group and 203 people in the control group). Using this information, we were able to calculate the RR for the cumulative incidence using the number of participants at risk at the start of the followup period (RR 0.87, 95% CI 0.69 to 1.09; 2513 participants). However, it is unlikely that all participants will have been observed for the entire period of follow-up due to loss to follow-up and competing risk of death (some participants may have died prior to the end of follow-up making it impossible to know whether they would have developed pneumonia if they had not died early because of another risk). Similarly, the cumulative incidence of a first pneumonia was reported in Juthani-Mehta 2015 ( 119 first episodes in 434 participants randomised in the intervention arm and 94 first episodes in 400 participants in the control arm). However, as the trial was stopped for futility, there was wide variation in the duration of follow-up for the participants and so the use of the number of randomised participants as a denominator may not be appropriate. Furthermore, the time period to which the incidence proportion relates is unclear. One study followed participants for 24 months and reported fewer participants with pneumonia in the professional oral care group ( 21 from 184) than the usual oral care group ( 34 from 182) ( low-quality evidence; RR 0.61, 95% CI 0.37 to 1.01; 366 participants) ( Yoneyama 2002). The use of the number of randomised participants as a denominator may not be appropriate.
Incidence proportion (cumulative incidence) of NHAP
Overall, no evidence of an effect was observed for the incidence proportion of NHAP, with data suggesting either an increase or decrease in the outcome is possible as a result of professional oral care.
Mortality (pneumonia-associated)
Three studies reported on pneumonia-associated death (Adachi 2002; Bourigault 2011; Yoneyama 2002) . There was no clear evidence of a difference between the groups who received professional oral care or usual oral care at 18-month follow-up (RR 1.09, 95% CI 0.58 to 2.05; one study, 2513 participants; Analysis 1.3). At 24-month follow-up, there was evidence that professional oral care may reduce pneumonia-associated mortality more than usual oral care (RR 0.41, 95% CI 0.24 to 0.72; two studies, 507 participants; Analysis 1.3; low-quality evidence).
Mortality (all-cause)
Two studies reported on all-cause mortality (Adachi 2002; Juthani-Mehta 2015). Very low-quality evidence indicated there was no clear difference in all-cause mortality between the groups who received professional oral care or usual oral care (RR 0.55, 95% CI 0.27 to 1.15; one study, 141 participants; Analysis 1.4). We considered it inappropriate to pool the data from Juthani-Mehta 2015, but the authors reported an HR of 1.16, 95% CI 0.88 to 1.53 at the time that the study was stopped.
Change in systemic antibiotic use
None of the studies measured this outcome.
Adverse reactions to the interventions
Juthani-Mehta 2015 stated that "there were no protocol-related serious adverse events, and there were 64 protocol-related non-serious adverse events, all of which were anticipated. The most common protocol-related non-serious adverse events were oral cavity disturbances and dental staining". The oral cavity disturbances included anything that could have been related to the oral care intervention, e.g. gum bleeding or mouth sores.
Incidence or prevalence of fever
No study reported fever by time-to-event data. Two studies reported the prevalence of fever (Adachi 2002; Yoneyama 2002) . Adachi 2002 stated that "the occurrence of fevers of 37.8°C or more in the POHC group was found to be significantly lower than that in the non-POHC group (P < 0.05)". They provided figures only, with no supporting data. Yoneyama 2002 reported the number of participants who had more than seven consecutive febrile days during the two-year period of follow-up. One study suggested that the risk of participants having fever was 51% lower in the professional oral care group (RR 0.49, 95% CI 0.33 to 0.75; 366 participants; Analysis 1.5).
Change in data on economics and quality of life
None of the studies measured the economics of oral care. Only one study measured change in quality of life measures ( Yoneyama 2002). The authors evaluated cognitive impairment with the Mini-Mental State Examination (MMSE), and activities of daily living (ADLs) with the modified Barthel Index. MMSE scores tend to reduce with age, but at the end of the 24-month follow-up, they noted that professional oral care mitigated this reduction in comparison to usual oral care (intervention group: 1.5 + 4.9, 170 participants; control group: 3.0 + 5.9, 152 participants; P = 0.032).
Oral health indices
Yoneyama 2002 reported a change in debris index. They found a debris index of 2.6 + 0.8 in the professional care group (109 participants), and of 2.5 + 0.8 in the usual care group (90 participants). Yoneyama 2002 dichotomised this outcome (improved or deteriorated) and concluded that professional oral care significantly reduced the debris index compared to usual care (RR 2.81, 95% CI 1.39 to 5.69, P = 0.004).
Oral care versus no oral care
No studies evaluated this comparison (see Summary of findings 2).
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D I S C U S S I O N
Summary of main results
The aim of this review was to assess the effects of oral care measures for preventing nursing-home acquired pneumonia (NHAP) in residents of nursing homes. We identified four eligible RCTs for the review. The studies focused on the comparison between professional oral care and usual oral care.
• It was not possible to establish the effects of professional oral care on the incidence rate of NHAP compared with usual oral care over an 18-month period (low-quality evidence).
• It was not possible to establish whether or not professional oral care can lower the number of first episodes of pneumonia compared with usual care over a 24-month period (low-quality evidence).
• Professional oral care may reduce pneumonia-associated death by 60% in comparison with usual oral care at 24-month follow-up (low-quality evidence).
• We could not draw any conclusions about the effect of professional oral care compared to usual care on all-cause mortality (very-low quality evidence).
• Adverse effects were measured in only one study, which was stopped early. This study identified no serious events.
We did not identify any studies that compared oral care to no oral care. Due to the limited quantity of included studies and low quality of the evidence, we should treat the results cautiously.
Overall completeness and applicability of evidence
Studies included in the review recruited participants residing in nursing homes. Some participants were dentate; some were edentulous. Some participants were able to care for themselves; others were not, possibly suffering from a variety of diseases. We considered that the results might be applicable to residents with different health conditions in nursing homes; however, no relevant data about the prevalence of systemic diseases were provided in the included studies. Two of studies included in the review were conducted in Japan (Adachi 2002; Yoneyama 2002) , one in the USA (Juthani-Mehta 2015), and one in France (Bourigault 2011). The review grouped oral care measures into professional oral care and usual oral care, but oral care protocols varied in both groups across studies. It was not possible to blind participants and caregivers to the oral care measures, which might have led to a Hawthorne effect, and influenced the results (Sedgwick 2015). All of our primary outcomes and most of our secondary outcomes were assessed in the review. Caregivers in nursing homes should understand that we only assessed the effect of oral care measures on new incidences of NHAP. Thus, the review does not provide evidence of whether oral care measures would affect the incidence or frequency of recurrent pneumonia. We noted that systemic diseases might be confounding factors that could influence the death of participants. Only Adachi 2002 reported all causes of death, and no studies made an attempt to analyse potential effects of these confounding factors. The studies also investigated the relationship between oral care measures and the administration of antibiotics. We were unable to acquire information about whether oral care measures could reduce expenses in nursing homes. In conclusion, evidence provided by this review might be applicable for a variety of residents in nursing homes, but it is essential to adequately consider the limitation and bias of studies included in the review, and to interpret the data with care.
Quality of the evidence
We assess all the included studies at high risk of bias due to the lack of blinding of participants; one study was also at high risk of bias owing to incomplete outcome data ( Figure 2 ). Due to the high risk of bias in the studies, the quality of evidence was downgraded one level for incidence rate and cumulative incidence of NHAP, and two levels for mortality (pneumonia-associated and all-cause). In most analyses, there was only one study that measured the outcome or the subgroup. One subgroup consisted of two studies with no heterogeneity (Analysis 1.3; 24-month follow-up; two studies; I² = 0%). Hence none of the evidence was downgraded for inconsistency. The number of events was mostly insufficient, reflected in the wide confidence intervals. So the evidence was downgraded for imprecision for incidence rate, cumulative incidence, and all cause mortality. None of the evidence was downgraded for indirectness. Due to the limited number of included studies, we did not generate a funnel plot to examine the publication bias across studies, thus none of the evidence was downgraded for this. Therefore, we downgraded the quality of evidence to low on incidence rate, cumulative incidence of NHAP, and pneumonia-associated mortality, and to very low on all-cause mortality (Summary of findings for the main comparison). We emphasise that it is necessary to treat the evidence with caution, due to the small number of included studies.
Potential biases in the review process
In order to reduce the risk of publication bias in our review, we conducted a broad search for both published and unpublished studies, with no restrictions on language. We searched the reference lists of included studies, and contacted many of the trial authors in order to obtain information that was not included in the published reports. We also searched the reference lists of other published reviews concerning oral care for nursing home residents. However, we still failed to acquire the data from a potentially relevant study, entitled 'Chlorhexidine & Pneumonia in Nursing Home Residents', registered in clinicaltrials.gov (NCT00841074). We did not include Ohsawa 2003 because we were unable to clarify whether the data were part of the study described in Yoneyama 2002. For this review, we also chose very broad inclusion criteria, which resulted in a clinically heterogeneous group of studies including elderly people who were either dentulous or edentulous, with or without cognitive impairment, and possibly with a variety of systemic diseases. The trial method was described poorly in some studies, which made it difficult to assess the similarity between studies. There might have been potential variation in the diagnoses and assessment of outcomes. Another potential bias in this review was that there is no gold standard used to diagnose NHAP. In data analysis, we assessed whether the follow-up duration of oral care measures influenced the results in a subgroup analysis. We noticed that oral care measures were provided by different caregivers, or participants themselves. Discrepancy in the performance of operators might influence results, but due to the limited studies and incomplete information, we did not attempt further analysis. The results from Juthani-Mehta 2015 were in contradiction to the results of the other included studies. We excluded it from meta-analysis due to the variable duration of follow-up among participants. Hence, we did not downgrade the relevant evidence due to inconsistency. Moreover, there are conflicting opinions as to whether trials stopped early should be included in a meta-analysis.
Agreements and disagreements with other studies or reviews
Other reviews of the effects of oral care measures on NHAP have been published (El-Rabbany 2015; Kaneoka 2015; Sjögren 2016). These three systematic reviews included participants in hospitals as well as nursing homes. El-Rabbany 2015 concluded that chlorhexidine might be an effective means of lowering the risk for hospitalacquired and ventilator-associated pneumonia, but the efficacy of other prophylactic oral care measures, such as tooth brushing or iodine swab, was uncertain. Kaneoka 2015 suggested a preventive effect of oral care measures on healthcare-associated pneumonia in participants without mechanical ventilation. Sjgren 2016 reported that oral care provided by dental personnel may reduce mortality from healthcare-associated pneumonia, whereas oral care provided by nursing personnel probably resulted in little or no difference from usual care. This Cochrane review found that professional oral care may reduce mortality due to pneumonia when compared to usual care at 24 months; however, our confidence in this effect estimate was limited. In terms of the incidence rate or proportion of NHAP, the limited body of evidence indicated that professional oral care may have little or no difference in these outcomes at 24 months. However, our confidence in these effects is limited.
A U T H O R S ' C O N C L U S I O N S
Implications for practice
Low-quality evidence suggested that professional oral care may reduce mortality due to pneumonia compared to usual care, when measured at 24 months. Low-quality evidence was inconclusive about the effects of professional care compared to usual oral care on incidence of nursing-home acquired pneumonia, number of first episodes of nursing-home acquired pneumonia, and mortality from any cause. The only study to measure adverse effects reported that there were no serious adverse effects. We found no highquality evidence to determine which oral care measures are most effective for reducing nursing home-acquired pneumonia. Further trials are needed to draw reliable conclusions.
Implications for research
Considering the limited number of trials in this field, there is a need for more trials focusing on the effect of oral care measures on nursing home-acquired pneumonia (NHAP) prevention. We hope future studies can address the following issues.
• Participants: studies with a large number of participants in nursing homes are expected. Sample size calculation and baseline comparability should be taken into consideration.
• Intervention: more oral care measures are needed in future RCTs, for instance, electronic toothbrush, dental floss, interdental brush, and different mouthrinses. More practical and flexible oral care protocols aimed at residents with different conditions could be used; for example, how can we ensure elderly people with dementia can accept the same oral care measures as mentally healthy residents? Measures for preventing aspiration should be considered as well.
• Comparisons: so far, all trials in this field focused on the comparison between professional oral care and usual oral care; future trials should consider comparisons of different oral care measures.
• Outcomes: we recommend that incidence with fixed follow-up duration, as time-to-event data, be measured. We also recommend that trials measure first and recurrent pneumonia. We suggest future studies include or analyse the participants based on stratification of NHAP risk factors, such as chronic obstructive pulmonary diseases, cardiovascular diseases, diabetes, and age. In addition, we hope future studies will pay more attention to systemic antibiotic use, economics, quality of life, and oral health indices.
• Risk of bias: future studies should find ways to reduce the risk of bias. Although blinding of participants and personnel may not be easy, blinding of outcome assessment should be achieved.
• Method of analyses: if there is uncertainty as to whether all participants can reasonably be followed for the entire follow-up period, then a time-to-event approach would be the most appropriate method of analysis. Analysing cumulative incidence as though all participants are observed for the entire follow-up period can lead to erroneous inferences.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Adachi 2002
Methods 
Interventions
Comparison: caregiver-provided professional oral care versus caregiver-provided usual oral care Intervention group: brushing teeth, buccal mucosa and tongue (electric brush with an automatic water supply, an interdental brush, a sponge brush) + cleaning denture, by dental hygienists Control group: swabbing teeth, buccal mucosa, tongue (sponge brush) + cleaning denture Operators: dental hygienists, number not stated As for daily oral care, those who were independent enough used the washing facilities in their rooms to rinse out their mouths after each meal, but the other participants were assisted to carry out oral cleansing once a day by the nursing home staff Outcomes Notes Sample size calculation: stated in detail. The target sample size was 828 participants to detect a 25% reduction in the cumulative 2.5-year first pneumonia rate with intervention relative to control assuming a type I error of 0.05 (2-sided), 80% power, an annual loss to follow-up rate of 20% (death, transfer out of the nursing home), equal allocation and an intracluster correlation (ICC) of 0.005 from a previous study 
Risk of bias
Notes
It was stated that the trial was completed, but no published articles retrieved and no useful data available. We tried to contact the authors for the data we needed. The author replied that "The study is finished but we did not obtain any significant results and they have not been published", but when we asked for further information, we received no further reply. The study will be considered for inclusion once the trial authors provide the outcome data
Ohsawa 2003
Methods Interventions Comparison: caregivers provided professional oral care versus usual oral care Intervention group (n = 25): brushing teeth (after each meal) + swabbing mucosa (with 1% povidone iodine, used in some cases), by nurses or caregivers + dental visit (twice or three times a week), by dentists or dental hygienists + cleaning denture (every day) Control group (n = 24): brushing teeth (after each meal), by caregivers + cleaning denture (every day) Operators: nurses, caregivers, dentists and dental hygienists. Number not stated 
D A T A A N D A N A L Y S E S
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